top of page

Elegant Abstract Background

Home
Donate
- Groups
- Members
For Patients
- Current Treatments
- Clinical Trials in the US
TVALA Clinical Trial
For Researchers
News
About
Contact
Privacy Policy
More

Use tab to navigate through the menu items.

Light microscope of Motor neurons of the spinal cord are part of the central nervous syste

Blog

NDR's TVALA® Trademarked

The lead molecule under development by NDR for treating neuroinflammation is the retro-inverso thymopentin, TVALA®. The application for...

Aug 31, 20221 min read

Sayuri Miyamoto to present a poster at the Paris Redox 2022 World Conference

NDR is pleased to congratulate Dr. Sayuri Miyamoto and her co-workers Adriano Chaves-Filho, Rosangela Santos, Rodrigo Lima, Larissa...

May 9, 20221 min read

Dr. Susanne Petri Joins NDR Scientific Group

NDR Inc is pleased to announce that Dr. Susanne Petri has joined our scientific group. Dr. Petri is an Associate Professor in the...

Mar 8, 20221 min read

NDR awards $1.54 M drug development contract to WuXi App Tec

New drug development

Jan 14, 20221 min read

Student Grant Awarded to Rodrigo Santiago Lima

Student grants in ALS

Jan 1, 20221 min read

Neurodegenerative

Disease Research, Inc.

© 2022 Neurodegenerative Research, Inc.

All rights reserved. Privacy Policy.

Marketing by ProSky Studio.

Subscribe for updates

Email

Thanks for subscribing!

Follow Us On:

bottom of page